Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% over the next 6 months [14]. Core Insights - A breakthrough in Alzheimer's treatment was observed when a focused ultrasound surgery unexpectedly improved the cognitive function of a patient, challenging the traditional belief that Alzheimer's is irreversible. This condition affects nearly 17 million patients in China, leading to significant caregiving burdens [4][5]. - The research team led by Professor Sun Bomin is exploring a new approach using high-energy ultrasound to directly stimulate brain neural circuits, with initial clinical trials showing an average improvement rate of about 50% among seven moderate to severe patients [5]. - The global brain-computer interface (BCI) market is projected to grow rapidly, with an estimated size of approximately $2.62 billion in 2024, reaching $2.94 billion in 2025, and potentially growing to $12.4 billion by 2034, reflecting a compound annual growth rate of 17.35% over the next decade [6]. Summary by Sections Industry Overview - The report highlights the significant unmet medical need in Alzheimer's treatment and the potential for innovative therapies to emerge from recent clinical findings [4][5]. Market Potential - The brain-computer interface market is expected to see substantial growth, with specific projections for both global and Chinese markets, indicating a strategic focus on high-tech industries as outlined in national economic plans [6]. Investment Recommendations - The report suggests monitoring companies such as Yanshan Technology, Hanwei Technology, Sanbo Brain Science, and others, which are positioned to benefit from advancements in the BCI and related technologies [6].

Group 1 - The event "Digital Intelligence Empowering Ecology 'Supply' Sharing New Future" was held in Chongming, Shanghai, focusing on regional development and capital market empowerment for the real economy [1][2] - Key stakeholders, including government officials and representatives from listed companies, participated in discussions on regional development, policy support, and innovative investment relations management [1] - The "Top 100 Secretaries" award ceremony recognized 200 outstanding secretaries and 10 excellent secretary teams, highlighting the importance of the capital market and the role of secretaries [1] Group 2 - A sub-forum on equity mergers and acquisitions provided a platform for companies to showcase their core advantages and link industry resources [2] - Several listed companies, including Huayou Cobalt and Dongxin Technology, participated in a roadshow, attracting over a hundred institutional professionals to facilitate efficient connections between listed companies and capital [2] - The event was co-hosted by Shenzhen Yao Research Technology Co., Chongming District Supply and Marketing Cooperative, and Shanghai Dongtan Construction Group, with support from Suzhou Investment Relations Technology Co. [2]

（文章来源：证券日报） 证券日报网讯 1月19日，东方中科在互动平台回答投资者提问时表示，截至1月10日（最新一期），公 司股东人数为37927户。 ...

Core Viewpoint - Oriental Zhongke's stock price has shown fluctuations, with a recent decline of 2.05% and a year-to-date increase of 8.28%, indicating mixed market sentiment towards the company [1]. Group 1: Stock Performance - As of January 15, Oriental Zhongke's stock price is reported at 29.57 CNY per share, with a trading volume of 84.02 million CNY and a turnover rate of 1.20%, resulting in a total market capitalization of 8.859 billion CNY [1]. - The stock has experienced a 1.20% decline over the past five trading days, a 10.29% increase over the last 20 days, and a 3.43% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Oriental Zhongke achieved a revenue of 2.012 billion CNY, reflecting a year-on-year growth of 3.24%, while the net profit attributable to shareholders was reported at -82.1855 million CNY, showing a slight increase of 2.04% year-on-year [2]. Group 3: Shareholder Information - As of December 31, the number of shareholders for Oriental Zhongke reached 28,000, an increase of 0.50% from the previous period, with an average of 8,402 circulating shares per shareholder, which decreased by 0.50% [2]. - The company has distributed a total of 113 million CNY in dividends since its A-share listing, with 29.178 million CNY distributed over the past three years [3]. - As of September 30, 2025, Hong Kong Central Clearing Limited is listed as the tenth largest circulating shareholder, holding 1.1954 million shares as a new shareholder [3]. Group 4: Business Overview - Oriental Zhongke, established on August 10, 2000, and listed on November 11, 2016, is based in Haidian District, Beijing, and specializes in providing comprehensive services including sales, leasing of electronic measuring instruments, and system integration [1]. - The company's main business revenue composition includes general testing services (67.50%), automotive testing (13.17%), government integration (10.46%), professional services (6.95%), security services (1.27%), iris recognition (0.34%), and other services (0.30%) [1].

证券日报网讯1月12日，东方中科（002819）在互动平台回答投资者提问时表示，截至2025年12月31 日，公司股东人数为27977户。 ...

东方中科(002819.SZ)今日低开低走，盘中一度跌4.4%至29.3元，最终收跌3.65%报29.53元，全天成交5.6亿元，最新市值88.47亿元。东方中科昨日晚间公 告，大连金融产业投资集团有限公司持股3460.68万股，占11.68%，计划2026年1月28日至2026年4月27日以集中竞价和大宗交易方式合计减持不超889.08万 股，占3%。(格隆汇) ...

Group 1 - The brain-computer interface sector in the A-share market experienced a significant decline, with multiple companies reporting substantial drops in their stock prices [1] - Major companies such as Mailland, Chengyitong, and Aipeng Medical saw declines exceeding 10%, while others like Leidi Ke and Weisi Medical dropped over 8% [1][2] - Several brain-computer interface concept stocks issued announcements indicating a cooling off, with companies like Aerospace Changfeng stating they have not actually engaged in related business activities [1] Group 2 - Mailland's stock fell by 11.09%, with a total market value of 54.43 billion [2] - Chengyitong's stock decreased by 10.91%, with a market capitalization of 6.731 billion [2] - Aipeng Medical's stock dropped by 10.39%, with a market value of 4.514 billion [2]

Summary of Key Points Core Viewpoint - Multiple shareholders from various companies are planning to reduce their stakes, indicating potential shifts in ownership and market dynamics [1]. Shareholder Reductions - **Shanwaishan**: Shareholders Yuanwaiyuan, Chongqing Dexiang, and Chongqing Derui plan to reduce a total of no more than 6.3747 million shares [1]. - **Oriental Zhongke**: Shareholder Dalian Jintou intends to reduce no more than 3% of its shares [1]. - **Mengke Pharmaceutical**: Shareholder Mengke Hong Kong plans to reduce no more than 3% of its shares [1]. - **Shengke Communication**: Shareholder National Integrated Circuit Industry Investment Fund plans to reduce no more than 3% of its shares [1]. - **Pioneer Electronics**: The controlling shareholder plans to reduce no more than 1% of its shares [1]. - **Heer Technology**: Chairman Liu Jianwei plans to reduce no more than 2% of his shares [1]. - **Sifang Jichuang**: The controlling shareholder and its concerted parties plan to reduce no more than 2% of their shares [1]. - **Yinbang Shares**: Shareholder Huaibei Public Utilities plans to reduce no more than 3% of its shares [1]. - **Fulaiwang**: The controlling shareholder plans to reduce no more than 2.9977% of its shares [1]. - **Thinking Control**: The company has terminated plans for a change in control and will resume trading on January 7 [1]. - **Baihua Pharmaceutical**: The company has also terminated plans for a change in control and will resume trading on January 7 [1].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002819 证券简称：东方中科 公告编号：2026-002 北京东方中科集成科技股份有限公司 关于持股5%以上股东减持股份预披露公告 本公司持股5%以上股东大连金融产业投资集团有限公司保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有本公司股份34,606,800股（占目前公司总股本比例11.68%）的股东大连金融产业投资集团有限公司 （以下简称"大连金投"），计划自本公告披露之日起15个交易日后的3个月内（2026年1月28日至2026年 4月27日），以集中竞价交易方式减持公司股份不超过2,963,600股，以大宗交易方式减持公司股份不超 过5,927,200股。本次合计减持公司股份不超过8,890,800股（约占公司目前总股本比例3.00%）。 1、减持原因：自身资金需求。 2、股份来源：协议转让受让的股份。 3、减持期间：本公告披露之日起15个交易日后的3个月内（2026年1月28日至2026年4月27日）（根据中 国证监会 ...

（记者 曾健辉） 每经AI快讯，东方中科1月6日晚间发布公告称，持有公司股份约3461万股（占目前公司总股本比例为 11.68%）的股东大连金融产业投资集团有限公司，计划自本公告披露之日起15个交易日后的3个月内 （2026年1月28日至2026年4月27日），以集中竞价交易方式减持公司股份不超过约296万股，以大宗交 易方式减持公司股份不超过约593万股。本次合计减持公司股份不超过约889万股（约占公司目前总股本 比例为3%）。 每经头条（nbdtoutiao）——原指导价34.99万的宝马裸车价22.5万元，多家车企还补贴购置税！2026开 年车市火爆，销售从早到晚忙到没空吃饭 ...